The traumatic segment by wound type is estimated to lead the market growth during the forecast period.

According to a new market research study of “South and Central America Single-Use Negative Pressure Wound Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Wound Type, End User and Country.” The South and Central America single use negative pressure wound therapy market is expected to reach US$ 42.92 million by 2028 from US$ 25.02 million in 2021; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028. The report highlights trends prevailing in the South and Central America single-use negative pressure wound therapy market and the factors driving market along with those that act as hindrances. 

Chronic diseases and their associated disorders are among the major indications affecting the human population globally. Chronic diseases can cause long-term injuries and make the healing of wounds such as post-surgical wounds and accident-led wounds difficult. Negative pressure wound therapy (NPWT) systems are used to manage and ease wound healing. The systems help in wound-healing through negative pressure (suction). They also help remove fluids such as irrigation solutions, bodily liquids, wound exudate, and infectious materials present in the wound area. According to a study published by National Center for Biotechnology Information (NCBI) in August 2020, about 5% of patients suffering from diabetes mellitus develop foot ulcers, and 1% need an amputation procedure globally. The patients in such conditions require periodic wound cleaning and dressing that can be accomplished using wound therapy devices. Continuous developments in medical devices related to wound therapy and the rise in prevalence of diseases such as diabetes and cancer—which might lead to ulcers, pressure ulcers, and wounds associated with different surgical procedures—are driving the single-use negative pressure wound therapy market. Also, single-use negative pressure wound therapy is among emerging technologies used for the management of burn-related wounds. Thus, the rise in burns and related injuries cases is driving the single-use negative pressure wound therapy devices market.

South and Central America has been witnessing a growing number of COVID-19 cases since its outbreak. State-run hospitals and clinics are already overstressed by the treatment of vector?borne diseases and community?acquired infections and high rates of non?communicable diseases (NCDs). Also, the prevention and treatment of NCDs have been critically affected since the onset of the COVID-19 in the region. These factors have potentially impacted the South and Central America single-use negative pressure wound therapy device market. As COVID-19 is contagious, patients prefer single-use products during wound care management. Hence, the rising awareness about the use of disposable products in wound management helped increase the demand for single-use NPWT devices in the South and Central America region, providing a favorable scenario for the single-use NPWT devices market in this region.

The South and Central America single-use negative pressure wound therapy devices market, based on the wound type was segmented into surgical, traumatic, diabetic foot, sports injuries, venous leg ulcers, and others. The South and Central America single-use negative pressure wound therapy devices market, based on the end user was segmented into hospitals, clinics, ambulatory surgical centers, and others. Geographically, the South and Central America single use negative pressure wound therapy market can be sub-segmented into Brazil, Argentina and Rest of South and Central America.

Cardinal Health Inc, ConvaTec Group Plc, Carilex Medical, Genadyne Biotechnologies, Inc., Lohmann & Rauscher GmbH & Co. KG, Medela AG, Mölnlycke Health Care AB, PAUL HARTMANN AG, and Smith & Nephew are among the leading companies operating in the South and Central America single-use negative pressure wound therapy market.